Form 4: Labcorp Legal Chief's Stock Transactions

Labcorp's EVP and Chief Legal Officer, Sandra D. van der Vaart, reported exercising stock options and selling shares on August 13, 2025.

Summary

• Sandra D. van der Vaart, Executive Vice President and Chief Legal Officer of Labcorp Holdings Inc., exercised 3,903 non-qualified stock options for common stock on August 13, 2025, at an exercise price of $131.43 per share.
• Concurrently, 3,903 shares of Labcorp common stock were sold at a price of $271.4249 per share on the same date.
• Following these transactions, the beneficial ownership of common stock for the reporting person is 2,273.6691 shares.
• The reported beneficial ownership also includes 30.1294 shares acquired on June 30, 2025, under the Labcorp Holdings Inc. Amended and Restated 2016 Employee Stock Purchase Plan.
• The exercised stock options were granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan and were fully exercisable, having vested in three equal annual installments beginning February 12, 2020.
• The number of shares and exercise price for the options were automatically adjusted due to the spin-off of Fortrea Holdings Inc. by Labcorp Holdings Inc.

Sentiment

Score: 6

Explanation: The filing details a routine insider transaction involving the exercise of stock options and a concurrent sale of shares, likely for tax and exercise cost coverage. This is a standard event for executives with equity compensation and does not indicate significant positive or negative operational news for the company itself, though the executive realized a substantial gain.

Positives

• The executive exercised stock options, indicating a realization of value from long-term incentive compensation.
• The exercise price of $131.43 is significantly lower than the sale price of $271.4249, demonstrating a substantial gain for the executive on the exercised options.
• The acquisition of additional shares through the Employee Stock Purchase Plan (ESPP) suggests ongoing participation in company equity programs.

Negatives

• The executive sold all shares acquired from the option exercise, which, while common for tax and cost coverage, does not increase the executive's direct ownership stake in the company.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: Provides transparency into executive compensation and stock ownership changes. The sale of shares by an executive could be viewed neutrally or slightly negatively if not understood as a 'sell-to-cover' transaction.
• Employees: Highlights the structure of executive equity compensation plans.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction where an executive exercised stock options and sold shares, likely to cover taxes and exercise costs. Such transactions are common and do not typically signal a change in the company's fundamental outlook or performance. Therefore, it does not provide a basis for a strong buy or sell recommendation, and a 'hold' stance is appropriate as this filing alone does not alter the investment thesis.

Keywords

Labcorp Holdings Inc., LH, Sandra D. van der Vaart, SEC Form 4, insider trading, stock options, common stock, executive compensation, stock sale, employee stock purchase plan, Fortrea spin-off